In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

2017 Focused Update on Dual Antiplatelet Therapy

Myocardial Disease
Acute Coronary Syndromes (ACS)
Cardiovascular Pharmacology and Pharmacotherapy

Chairpersons: Marco Valgimigli

Publication date: 2017



Order Pocket Guidelines

 

Table of contents

  • ESC Tables of recommendations and levels of evidence
  • Introduction
  • Risk stratification tools for DAPT duration, measures to minimize bleeding, recommendations on PY12 inhibitor selection of timing and switching algorithms
  • DAPT and percutaneous coronary intervention
  • DAPT and cardiac surgery
  • DAPT for patients with medically managed acute coronary syndrome
  • DAPT for patients with indication for oral anticoagulation
  • Elective noncardiac surgery in patients on DAPT
  • Gender consideration, special populations and management of bleeding in patients treated with dual antiplatelet therapy with or without concomitant oral anticoagulation